Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.884
+0.032 (3.75%)
Dec 5, 2025, 4:00 PM EST - Market closed

Oragenics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-10.9-10.57-20.66-14.29-15.71-26.43
Upgrade
Depreciation & Amortization
--0.030.040.040.05
Upgrade
Loss (Gain) From Sale of Assets
--0.03-0.01--
Upgrade
Asset Writedown & Restructuring Costs
--10.27---
Upgrade
Stock-Based Compensation
00.521.020.741.691.49
Upgrade
Other Operating Activities
-----7.9
Upgrade
Change in Accounts Payable
0.87-0.120.030.180.01-0.6
Upgrade
Change in Other Net Operating Assets
0.831.571.99-1.890.50.64
Upgrade
Operating Cash Flow
-8.43-8.6-7.29-15.23-13.47-16.95
Upgrade
Capital Expenditures
----0.13-0.04-
Upgrade
Sale of Property, Plant & Equipment
--0.060.01--
Upgrade
Other Investing Activities
---1---
Upgrade
Investing Cash Flow
---0.94-0.12-0.04-
Upgrade
Short-Term Debt Issued
-----0.13
Upgrade
Total Debt Issued
2.62----0.13
Upgrade
Short-Term Debt Repaid
--0.69-0.57-0.56-0.52-0.33
Upgrade
Total Debt Repaid
-3.59-0.69-0.57-0.56-0.52-0.33
Upgrade
Net Debt Issued (Repaid)
-0.97-0.69-0.57-0.56-0.52-0.2
Upgrade
Issuance of Common Stock
2.646.670.850.0729.316.52
Upgrade
Financing Cash Flow
16.695.980.28-0.4923.1416.32
Upgrade
Net Cash Flow
8.26-2.62-7.94-15.849.63-0.63
Upgrade
Free Cash Flow
-8.43-8.6-7.29-15.36-13.51-16.95
Upgrade
Free Cash Flow Margin
---19363.34%-11675.70%-15535.76%-
Upgrade
Free Cash Flow Per Share
-6.66-38.95-97.23-229.30-208.66-539.85
Upgrade
Cash Interest Paid
0.030.030.030.010.020.01
Upgrade
Levered Free Cash Flow
-5.57-6.45-9.23-10.59-8.27-7.46
Upgrade
Unlevered Free Cash Flow
-5.85-6.43-9.21-10.58-8.26-7.46
Upgrade
Change in Working Capital
1.71.452.02-1.720.510.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.